Deleting Cgas in the P301S mice reduced tauopathy-induced microglial IFN-I, protected against synapse loss, synaptic plasticity deficits, and cognitive impairment, though it did not affect tau pathology levels. This evidence concerns the gene CGAS and tauopathy.